- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 10.23 ↓ -0.1%
[as on 6 March, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of PGIM India Healthcare Fund - Direct Plan - Growth Option and its peers as on 6 March, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| PGIM India Healthcare Fund - Direct Plan - Growth Option | 2.3% | -0.1% | -0.2% | 5.03% | 0.59% | 13.79% | - | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -6.88% | -0.48% | -2.33% | -2.98% | -7.15% | 0.58% | 13.01% | 15.94% | 15.17% | 15.96% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -5.68% | -1.18% | -3.5% | -3.99% | -6.28% | 8.33% | 13.66% | 11.75% | 13.69% | 13.62% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 2.01% | -0.09% | -0.62% | 4.31% | 0.05% | 8.52% | 27.17% | 18.41% | 21.54% | 13.29% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -4.22% | -0.61% | -3.2% | -3.17% | -3.24% | 8.99% | 20.54% | 19.96% | 19.54% | 17.48% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 6.09% | -0.46% | -2.93% | 1.91% | 8.44% | 29.55% | 33.66% | 28.09% | 21.61% | 17.17% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | - | -1.67% |
Discrete returns (monthly)
| Month | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 |
|---|
| Returns | 0.21% | 3.53% | 2.91% | -1.59% | -2.22% | 4.62% | 0.2% | -1.86% | -5.3% | 7.35% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 97.50% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
2.50% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.89% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 9.82% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 7.10% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 6.35% |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 5.53% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 4.76% |
| JB Chemicals & Pharmaceuticals Ltd. | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 4.53% |
| Rubicon Research Ltd. | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 3.87% |
| Krishna Inst of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 3.69% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 3.52% |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 3.25% |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 2.93% |
| Dr. Lal Path Labs Ltd. | LALPATHLAB (INE600L01024) | Healthcare Services | 2.90% |
| Navin Fluorine International Ltd. | NAVINFLUOR (INE048G01026) | Chemicals & Petrochemicals | 2.89% |
| PB Fintech Ltd. | POLICYBZR (INE417T01026) | Financial Technology (Fintech) | 2.82% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 2.58% |
| Jupiter Life Line Hospitals Ltd. | JLHL (INE682M01012) | Healthcare Services | 2.57% |
| Neuland Laboratories Ltd. | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 2.56% |
| Sai Life Sciences Ltd | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.30% |
| ICICI Lombard General Insurance Co. Ltd. | ICICIGI (INE765G01017) | Insurance | 2.12% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.82% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 1.71% |
| Rainbow Children's Medicare Ltd. | RAINBOW (INE961O01016) | Healthcare Services | 1.62% |
| Sagility Ltd. | SAGILITY (INE0W2G01015) | IT - Services | 1.55% |
| Lenskart Solutions Private Ltd. # | INE956O01016 | Retailing | 0.94% |
| Orchid Pharma Ltd. | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 0.80% |
| Dr Agarwal's Eye Hospital Ltd. | INE934C01018 | Healthcare Services | 0.58% |
| Dr Agarwal's Health Care Ltd. | AGARWALEYE (INE943P01029) | Healthcare Services | 0.57% |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 0.48% |
| Blue Jet Healthcare Ltd. | BLUEJET (INE0KBH01020) | Pharmaceuticals & Biotechnology | 0.45% |
Portfolio data is as on date 31 October, 2025
NAV history
PGIM India Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV |
|---|
| 6 March, 2026 | 10.23 |
| 5 March, 2026 | 10.24 |
| 4 March, 2026 | 10.14 |
| 2 March, 2026 | 10.23 |
| 27 February, 2026 | 10.25 |
| 26 February, 2026 | 10.36 |
| 25 February, 2026 | 10.27 |
| 24 February, 2026 | 10.16 |
| 23 February, 2026 | 10.18 |
| 20 February, 2026 | 10.06 |
| 19 February, 2026 | 10.08 |
| 18 February, 2026 | 10.11 |
| 17 February, 2026 | 10.08 |
| 16 February, 2026 | 10.02 |
| 13 February, 2026 | 9.93 |
| 12 February, 2026 | 10 |
| 11 February, 2026 | 10.03 |
| 10 February, 2026 | 9.91 |
| 9 February, 2026 | 9.88 |
| 6 February, 2026 | 9.74 |
| 5 February, 2026 | 9.71 |
| 4 February, 2026 | 9.68 |
| 3 February, 2026 | 9.72 |
| 2 February, 2026 | 9.47 |
| 30 January, 2026 | 9.53 |
| 29 January, 2026 | 9.42 |
| 28 January, 2026 | 9.53 |
| 27 January, 2026 | 9.52 |
| 23 January, 2026 | 9.48 |
| 22 January, 2026 | 9.62 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The latest NAV of PGIM India Healthcare Fund - Direct Plan - Growth Option is 10.23 as on 6 March, 2026.
What are YTD (year to date) returns of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The YTD (year to date) returns of PGIM India Healthcare Fund - Direct Plan - Growth Option are 2.3% as on 6 March, 2026.
What are 1 year returns of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The 1 year returns of PGIM India Healthcare Fund - Direct Plan - Growth Option are 13.79% as on 6 March, 2026.